Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Dartmouth's Digital App Targets Stress Relief for EMS Workers
Digital Health Dartmouth's Digital App Targets Stress Relief for EMS Workers

In the high-stress world of emergency medical services (EMS), managing job-related pressure is a constant challenge for clinicians who often find themselves in unpredictable and high-pressure situations, far removed from immediate support. Recognizing this ongoing issue, Dartmouth's Geisel School

UIH Transforms Diagnostics with AI and Precision Imaging
Imaging & Diagnostics UIH Transforms Diagnostics with AI and Precision Imaging

Increasing precision in medical diagnostics is a pivotal development, transforming how healthcare systems operate globally. United Imaging Healthcare (UIH) has emerged at the forefront of driving this evolution by integrating artificial intelligence and precision imaging. This technological

Diagnostic Imaging Market: Growth and Trends to 2035
Imaging & Diagnostics Diagnostic Imaging Market: Growth and Trends to 2035

The diagnostic imaging market, integral to global healthcare technology, is witnessing remarkable expansion fueled by technological advancements and rising medical demands. Encompassing a variety of imaging modalities—such as X-ray, MRI, CT scans, ultrasound, and nuclear imaging—this sector plays a

Why Are Medical Device Recalls Critical for Patient Safety?
Regulatory & Compliance Why Are Medical Device Recalls Critical for Patient Safety?

In the fast-evolving world of medical devices, maintaining compliance with regulatory standards is vitally important. James Maitland, an expert in robotics and IoT applications in medicine, shares insights into the recent developments with Q’Apel Medical, a company that faced significant challenges

How Will Drug Price Transparency Impact PBMs and Costs?
Regulatory & Compliance How Will Drug Price Transparency Impact PBMs and Costs?

In a rapidly evolving healthcare market, drug price transparency emerges as a pivotal issue shaping the future financial landscape. Amid calls for reform and increased regulation, the focus shifts to the powerful role of Pharmacy Benefit Managers (PBMs). Transparency promises potential shifts in

Period Tracking Apps and the Battle for Digital Privacy Rights
Regulatory & Compliance Period Tracking Apps and the Battle for Digital Privacy Rights

In the wake of heightened digital surveillance and the erosion of privacy, concerns about period tracking apps have come to the forefront, particularly since the U.S. Supreme Court's decision to overturn Roe v. Wade. The use and access to reproductive data have become hotly contested. Period

Can Medicaid Cuts Collapse Rural Healthcare Systems?
Regulatory & Compliance Can Medicaid Cuts Collapse Rural Healthcare Systems?

The looming threat of Medicaid funding cuts casts a dark cloud over the already precarious rural healthcare systems across America. As legislative discussions progress with proposals aimed at trimming Medicaid expenditures, rural hospitals find themselves grappling with an uncertain future. This

Can RFK Jr. Reshape Vaccine Policy Amid Controversy?
Regulatory & Compliance Can RFK Jr. Reshape Vaccine Policy Amid Controversy?

In today's interview, we dive into the monumental changes happening within the CDC’s vaccine recommendation committee. We are joined by James Maitland, though not directly involved, his insights into regulatory and policy changes are incredibly valuable due to his extensive expertise in technology

Will a Blood Test Transform Alzheimer's Diagnosis?
Imaging & Diagnostics Will a Blood Test Transform Alzheimer's Diagnosis?

In recent years, the field of Alzheimer's disease diagnosis has witnessed a transformative development with the advent of a cutting-edge blood test. Researchers at the Mayo Clinic have validated a diagnostic blood test that could revolutionize how Alzheimer's is detected, boasting a 95% sensitivity

Can New Leadership Advance Texas Tech's Medical Impact?
Imaging & Diagnostics Can New Leadership Advance Texas Tech's Medical Impact?

Texas Tech University's Paul L. Foster School of Medicine has recently welcomed Dr. Eric Rohren as the new dean, a pivotal appointment that promises to shape the future of medical education and service in El Paso. Rohren, transitioning from a prestigious role at Baylor College of Medicine, takes

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later